- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | Nexgel hydrogel patch reduces laser plume in hair removal study | 3 | Investing.com | ||
| Di | NEXGEL, INC.: NEXGEL Reports Positive Data from Randomized Single-Center IRB Study to Evaluate the Effectiveness and Safety of a Hydrogel Laser Treatment Patch in Laser Hair Removal with a 95.6% Reduction in Plume Concentration | 1 | GlobeNewswire (USA) | ||
| Fr | Earnings Call zu Q1 2026: Nexgel meldet Umsatzrückgang, Aktie gibt nach | 2 | Investing.com Deutsch | ||
| NEXGEL Aktie jetzt für 0€ handeln | |||||
| Fr | NexGel Q1 2026 Earnings Call Transcript | 2 | Benzinga.com | ||
| Fr | NEXGEL GAAP EPS of -$0.11 misses by $0.04, revenue of $2.65M misses by $1.26M | 1 | Seeking Alpha | ||
| Do | NEXGEL, INC. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
| 13.05. | NEXGEL, INC.: NEXGEL Appoints Dave Hazard as Vice President of Sales for BIONX Surgical | 1 | GlobeNewswire (USA) | ||
| 12.05. | NEXGEL, INC. - 8-K, Current Report | 1 | SEC Filings | ||
| 12.05. | NEXGEL, INC.: NEXGEL To Report First Quarter 2026 Financial Results on May 15th | 2 | GlobeNewswire (USA) | ||
| 06.05. | NEXGEL, INC.: NEXGEL Appoints Brian Kieser and Kevin Harris from New Strategic Partner, Sequence LifeScience, to Board of Directors | 2 | GlobeNewswire (USA) | ||
| 30.04. | NEXGEL, INC. - 10-K/A, Annual Report | 1 | SEC Filings | ||
| 30.04. | NEXGEL, INC. - 8-K, Current Report | 11 | SEC Filings | ||
| 22.04. | NEXGEL expects pro forma annual revenue of roughly $35M following Celularity wound segment acquisition | 3 | Seeking Alpha | ||
| 21.04. | NEXGEL, INC. - 8-K, Current Report | - | SEC Filings | ||
| 21.04. | NEXGEL schließt Biomaterialien-Deal mit Celularity ab und sichert sich 5,5 Millionen US-Dollar | 6 | Investing.com Deutsch | ||
| 21.04. | Celularity Inc.: Celularity Announces Closing of Transaction with NexGel | 179 | GlobeNewswire (Europe) | FLORHAM PARK, N.J., April 21, 2026 (GLOBE NEWSWIRE) -- Celularity Inc. (Nasdaq: CELU) ("Celularity"), a longevity-focused regenerative and cellular medicine company, today announced the closing of... ► Artikel lesen | |
| 17.04. | NEXGEL, INC.: NEXGEL Moves Forward Shareholder Update Call to Discuss Celularity Transaction on April 21st at 4:30 P.M. ET | 1 | GlobeNewswire (USA) | ||
| 05.04. | Nexgel: EPS verfehlt Schätzungen um 0,09 $ - Umsatz schlechter als erwartet | 11 | Investing.com Deutsch | ||
| 31.03. | NEXGEL, INC. - 10-K, Annual Report | - | SEC Filings | ||
| 25.03. | NEXGEL, INC.: NEXGEL to Report Fourth Quarter and Full Year 2025 Financial Results on March 31st | 1 | GlobeNewswire (USA) |
1 2 Weiter >>
37 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| INNOVAQOR | - | - | InnovaQor, Inc. - REVOKED, Commission order revoking Exchange Act registration [Section 12(j)] | ||
| BRIGHTSPRING HEALTH SERVICES | 56,72 | 0,00 % | BrightSpring Health Services, Inc. Reports First Quarter 2026 Financial Results and Increases Full Year 2026 Guidance | LOUISVILLE, Ky., May 01, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 16,360 | 0,00 % | Alignment Healthcare USA, LLC: Alignment Health Plan Recognized as One of Four Medicare Advantage Prescription Drug Plans in the U.S. for 2026 Excellence in Quality | ||
| PROCEPT BIOROBOTICS | 25,910 | 0,00 % | PROCEPT BioRobotics Reports First Quarter 2026 Financial Results | SAN JOSE, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| CO-DIAGNOSTICS | 1,990 | +1,02 % | Co-Diagnostics Reports First Quarter 2026 Financial Results | Advancing Global Commercialization Through CoSara Regulatory Progress and Regional Expansion
Executing Clinical Strategy with Upper Respiratory Submission Preparation... ► Artikel lesen | |
| BILLIONTOONE | 82,29 | 0,00 % | Jim Cramer on BillionToOne: "I Say Buy It" | ||
| HEARTFLOW | 26,620 | +0,08 % | Heartflow, Inc.: Heartflow Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance | SAN FRANCISCO, May 14, 2026 (GLOBE NEWSWIRE) -- Heartflow, Inc. (Heartflow) (Nasdaq: HTFL), the leader in AI technology for coronary artery disease (CAD), today reported financial results for the... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 23,290 | 0,00 % | Privia Health im ersten Quartal 2026: Umsatz schlägt Prognosen, Gewinn pro Aktie enttäuscht deutlich | ||
| PROGYNY | 24,610 | +0,04 % | Canaccord upgrades Progyny stock rating to buy on guidance beat streak | ||
| ADAPTHEALTH | 10,350 | 0,00 % | AdaptHealth Corp. - 10-Q, Quarterly Report | ||
| GENEDX | 42,190 | +0,14 % | GeneDx (WGS) Fell Despite Continued Execution Improvement | ||
| AVEANNA HEALTHCARE | 7,630 | 0,00 % | Aveanna Healthcare Holdings, Inc: Aveanna Healthcare Holdings Announces First Quarter Financial Results and Revised 2026 Guidance | First Quarter Revenue was $647.9 million, a 15.9% increase over the prior year periodFirst Quarter Net income was $41.7 million compared to $5.2 million for the prior year periodAdjusted EBITDA for... ► Artikel lesen | |
| LUMEXA IMAGING | 7,000 | 0,00 % | Lumexa Imaging Adds Four New Imaging Centers As It Expands Across The Southeast And Mid-Atlantic | ||
| LIFESTANCE HEALTH GROUP | 7,720 | -0,13 % | LifeStance Health Group, Inc.: LifeStance Reports First Quarter 2026 Results | SCOTTSDALE, Ariz., May 07, 2026 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial results... ► Artikel lesen | |
| MIMEDX | 3,640 | 0,00 % | MiMedx Group, Inc: MIMEDX Announces Launch of G4Derm Plus | Flowable Biomimetic Matrix Adds Self-Assembling Peptide Technology to Company's Portfolio G4Derm Plus Added to Premier and Vizient GPO Agreements MARIETTA, Ga., May 08, 2026 (GLOBE NEWSWIRE) -- MiMedx... ► Artikel lesen |
NEXGEL INC gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von -0,026 (-4,22 %) liegt der Kurs bei 0,588 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu NEXGEL INC finden Sie auf Wallstreet Online.